These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27557994)

  • 1. The Societal Cost of Schizophrenia: A Systematic Review.
    Jin H; Mosweu I
    Pharmacoeconomics; 2017 Jan; 35(1):25-42. PubMed ID: 27557994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness Studies.
    Lin C; Zhang X; Jin H
    Pharmacoeconomics; 2023 Feb; 41(2):139-153. PubMed ID: 36404364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-of-illness studies for bipolar disorder: systematic review of international studies.
    Jin H; McCrone P
    Pharmacoeconomics; 2015 Apr; 33(4):341-53. PubMed ID: 25576148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
    Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
    Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cost of schizophrenia: a literature review].
    Charrier N; Chevreul K; Durand-Zaleski I
    Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The main cost drivers in dementia: a systematic review.
    Schaller S; Mauskopf J; Kriza C; Wahlster P; Kolominsky-Rabas PL
    Int J Geriatr Psychiatry; 2015 Feb; 30(2):111-29. PubMed ID: 25320002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries.
    Kotzeva A; Mittal D; Desai S; Judge D; Samanta K
    J Med Econ; 2023; 26(1):70-83. PubMed ID: 36503357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-of-illness studies of inherited retinal diseases: a systematic review.
    Ng QX; Ong C; Yaow CYL; Chan HW; Thumboo J; Wang Y; Koh GCH
    Orphanet J Rare Dis; 2024 Feb; 19(1):93. PubMed ID: 38424595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-of-Illness in Rare Diseases.
    Linertová R; García-Pérez L; Gorostiza I
    Adv Exp Med Biol; 2017; 1031():283-297. PubMed ID: 29214579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.
    Iragorri N; de Oliveira C; Fitzgerald N; Essue B
    Appl Health Econ Health Policy; 2021 May; 19(3):325-341. PubMed ID: 33368032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review.
    Zemedikun DT; Kigozi J; Wynne-Jones G; Guariglia A; Roberts T
    PLoS One; 2021; 16(5):e0251406. PubMed ID: 33974661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct healthcare cost of schizophrenia - European overview.
    Kovács G; Almási T; Millier A; Toumi M; Horváth M; Kóczián K; Götze Á; Kaló Z; Zemplényi AT
    Eur Psychiatry; 2018 Feb; 48():79-92. PubMed ID: 29428166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of schizophrenia in Canada in 2004.
    Goeree R; Farahati F; Burke N; Blackhouse G; O'Reilly D; Pyne J; Tarride JE
    Curr Med Res Opin; 2005 Dec; 21(12):2017-28. PubMed ID: 16368053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression: cost-of-illness studies in the international literature, a review.
    Berto P; D'Ilario D; Ruffo P; Di Virgilio R; Rizzo F
    J Ment Health Policy Econ; 2000 Mar; 3(1):3-10. PubMed ID: 11967432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.
    Pike J; Grosse SD
    Appl Health Econ Health Policy; 2018 Dec; 16(6):765-778. PubMed ID: 30094591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-of-illness studies of diabetes mellitus: a systematic review.
    Ng CS; Lee JY; Toh MP; Ko Y
    Diabetes Res Clin Pract; 2014 Aug; 105(2):151-63. PubMed ID: 24814877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of schizophrenia in South Korea.
    Chang SM; Cho SJ; Jeon HJ; Hahm BJ; Lee HJ; Park JI; Cho MJ
    J Korean Med Sci; 2008 Apr; 23(2):167-75. PubMed ID: 18436996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.
    Paz-Zulueta M; Parás-Bravo P; Cantarero-Prieto D; Blázquez-Fernández C; Oterino-Durán A
    Mult Scler Relat Disord; 2020 Aug; 43():102162. PubMed ID: 32442885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.